ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling ProgramsPRNewsWire • 09/30/21
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101PRNewsWire • 09/28/21
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease PatientsPRNewsWire • 07/22/21
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial SitesPRNewsWire • 06/23/21
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA FilingPRNewsWire • 06/22/21
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory BoardPRNewsWire • 06/15/21
JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101PRNewsWire • 06/08/21
JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery DiseasePRNewsWire • 09/22/20
JanOne Selects Partner for Bottling and Labeling of JAN101 for Peripheral Artery Disease and Potential Covid-19 Clinical TrialsPRNewsWire • 08/28/20
JanOne Advances its Potential Peripheral Artery Disease and Covid-19 Vascular Inflammation Treatment Towards Trial ReadinessPRNewsWire • 08/26/20
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call TranscriptSeeking Alpha • 08/26/20
JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Potential Applications for COVID-19 Vascular ComplicationsPRNewsWire • 08/21/20
JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical TrialsPRNewsWire • 08/11/20
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular ComplicationsPRNewsWire • 08/06/20
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional painPRNewsWire • 07/30/20